Case Study

Development Of Non-Biohazardous p24 Antigen Expressing Synthetic Cells As A Reference Control Alternative To HIV+ Donor Samples


Slingshot Biosciences partnered with a Fortune 100 pharmaceutical company to address their interest in using HIV-1 p24 expression as a marker for translation-competent HIV-infected cells. The companies HIV treatment research requires the use of HIV-infected cells from viremic HIV+ blood donors, which present biohazard risks and limitations around sample variability.

Slingshot worked to engineer a p24-expressing, non-infectious synthetic T cell mimic that could safely, reproducibly, and conveniently be used as a cellular reference control for detecting p24 antigen-positive T-cells in HIV+ patients.

access the Case Study!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene

Slingshot Biosciences, Inc.